| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1534735406288443 |
| P698 | PubMed publication ID | 16685077 |
| P50 | author | Keith I Block | Q94114016 |
| P2093 | author name string | Mark F McCarty | |
| P2860 | cites work | Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer. | Q53268582 |
| Thrombin receptor expression is upregulated in prostate cancer. | Q53652220 | ||
| Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. | Q53891794 | ||
| Nutritional supplementation of the leucine metabolite beta-hydroxy-beta-methylbutyrate (hmb) during resistance training. | Q54037648 | ||
| Immune receptors for polysaccharides from Ganoderma lucidum. | Q54702908 | ||
| An in vivo study of hepatic and splenic interleukin-1 beta mRNA expression following oral PSK or LEM administration. | Q55109509 | ||
| Diet and body mass index in 38 000 EPIC-Oxford meat-eaters, fish-eaters, vegetarians and vegans | Q57421556 | ||
| Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial | Q57943255 | ||
| Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling | Q24307907 | ||
| Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors | Q24676378 | ||
| Oxygen-regulated transcription factors and their role in pulmonary disease | Q24791474 | ||
| One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women | Q24800268 | ||
| Prevention of Cancer Through Lifestyle Changes | Q24808755 | ||
| IL-12 Production Induced by Agaricus blazei Fraction H (ABH) Involves Toll-like Receptor (TLR) | Q24808841 | ||
| Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. | Q24816287 | ||
| Suppression of metastasis by nuclear factor kappaB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma | Q28166746 | ||
| A prospective study of plasma C-peptide and colorectal cancer risk in men | Q28168133 | ||
| Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells | Q28184794 | ||
| Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells | Q28184976 | ||
| Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells | Q28192896 | ||
| Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma | Q28194117 | ||
| Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes) | Q28216802 | ||
| Tissue factor and fibrin in tumor angiogenesis | Q28251842 | ||
| Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people | Q28285488 | ||
| Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans | Q28289663 | ||
| Role of chromium in human health and in diabetes | Q28289713 | ||
| A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet | Q28298898 | ||
| Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease | Q28369787 | ||
| Folate: a key to optimizing health and reducing disease risk in the elderly | Q28645810 | ||
| Inhibition of NF-kappa B by sodium salicylate and aspirin | Q29614708 | ||
| The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta | Q29617188 | ||
| Magnesium deficiency is associated with insulin resistance in obese children. | Q30436679 | ||
| Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone | Q30438085 | ||
| The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis Cleaves and inactivates plasminogen activator inhibitor type 1. | Q30666324 | ||
| Effect of glutamine supplementation of the diet on tissue protein synthesis rate of glucocorticoid-treated rats | Q31881027 | ||
| Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice | Q32065119 | ||
| Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate | Q32159522 | ||
| PTHrP gene expression in cancer: do all paths lead to Ets? | Q33705984 | ||
| The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer | Q33874156 | ||
| Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. | Q33909028 | ||
| Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss | Q33950842 | ||
| Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine | Q33958795 | ||
| Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial | Q33968290 | ||
| Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). | Q33977885 | ||
| An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort | Q33979114 | ||
| Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy | Q33980579 | ||
| Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate | Q33983462 | ||
| The relationship between a urinary cachectic factor and weight loss in advanced cancer patients | Q33984284 | ||
| Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss | Q33984500 | ||
| NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle | Q33985083 | ||
| Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model | Q33986996 | ||
| Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor | Q34057583 | ||
| Induction of muscle protein degradation by a tumour factor | Q34065542 | ||
| Nuclear factor-kappaB: the enemy within | Q35893620 | ||
| Tumor-host interactions | Q35902161 | ||
| Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways | Q35926915 | ||
| Hypercoagulability in the metabolic syndrome. | Q36076184 | ||
| Molecular signaling pathways regulating muscle proteolysis during atrophy | Q36089017 | ||
| Parathyroid hormone-related protein in prostate cancer | Q36098134 | ||
| On the role of galectin-3 in cancer apoptosis | Q36103556 | ||
| The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). | Q36114755 | ||
| Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer | Q36126566 | ||
| Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging | Q36141285 | ||
| The insulin-like growth factor-I receptor as a target for cancer therapy | Q36219706 | ||
| Failure of vitamin E in clinical trials: is gamma-tocopherol the answer? | Q36270921 | ||
| Current insights into the role of transforming growth factor-beta in bone resorption. | Q36283949 | ||
| Multifocal angiostatic therapy: an update | Q36311166 | ||
| I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss | Q36402985 | ||
| Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D. | Q36615246 | ||
| Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study | Q36621976 | ||
| Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB. | Q36648384 | ||
| Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy | Q36689936 | ||
| Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer | Q36975194 | ||
| Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. | Q38289775 | ||
| Transcriptional regulation of tissue factor expression in human endothelial cells | Q38295839 | ||
| Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism | Q38296040 | ||
| Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway | Q38304915 | ||
| Involvement of Nuclear Factor-κB in the Inhibition of Interleukin-12 Production from Mouse Macrophages by Baicalein, a Flavonoid inScutellaria baicalensis | Q38349534 | ||
| Role of protein kinase C and NF-kappaB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes | Q38799171 | ||
| Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation | Q38802465 | ||
| Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells | Q40414489 | ||
| Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice. | Q40416233 | ||
| Autocrine metabolism of vitamin D in normal and malignant breast tissue | Q40427845 | ||
| Inhibition of interleukin-12 production in mouse macrophages via decreased nuclear factor-kappaB DNA binding activity by myricetin, a naturally occurring flavonoid | Q40434748 | ||
| Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways | Q40495382 | ||
| IKKbeta/NF-kappaB activation causes severe muscle wasting in mice | Q40505119 | ||
| Signalling pathways in the induction of proteasome expression by proteolysis-inducing factor in murine myotubes | Q40510613 | ||
| Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis | Q40558772 | ||
| Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts | Q40568556 | ||
| PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway | Q40578212 | ||
| Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications | Q40585883 | ||
| The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D. | Q40598330 | ||
| Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer | Q40626611 | ||
| Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion. | Q40652893 | ||
| Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells | Q40665255 | ||
| Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways | Q40745072 | ||
| Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse | Q40755997 | ||
| Natural history of HLA expression during tumour development. | Q40797268 | ||
| Tumor cell adhesion to endothelial cells is increased by endotoxin via an upregulation of beta-1 integrin expression | Q40810258 | ||
| Monomethyl selenium--specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation | Q40828475 | ||
| Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages | Q40887948 | ||
| Antiproliferative activity of flavonoids on several cancer cell lines | Q40946396 | ||
| The NF-kappaB binding site is essential for transcriptional activation of the IL-15 gene | Q41040079 | ||
| Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B. | Q41085611 | ||
| Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase | Q41087163 | ||
| The noncalcemic vitamin D analogues EB1089 and 22-oxacalcitriol interact with the vitamin D receptor and suppress parathyroid hormone-related peptide gene expression | Q41120912 | ||
| Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression | Q41129739 | ||
| Harry M. Vars Research Award. Glutamine enhances immunoregulation of tumor growth | Q41433982 | ||
| Point of view--a role for "nutritional insurance" supplementation in preventive medicine | Q41633269 | ||
| Pharmacological interference with tissue hypercatabolism in tumour-bearing rats | Q42142955 | ||
| Hypoxia-associated induction of early growth response-1 gene expression | Q42472170 | ||
| Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. | Q42528232 | ||
| Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor | Q42559551 | ||
| Inhibition of 15-lipoxygenases by flavonoids: structure-activity relations and mode of action | Q43486331 | ||
| Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism | Q43564045 | ||
| Growth hormone together with glutamine-containing total parenteral nutrition maintains muscle glutamine levels and results in a less negative nitrogen balance after surgical trauma | Q43594348 | ||
| The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study | Q43698055 | ||
| Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. | Q43718558 | ||
| Glutamine supplementation in cancer patients | Q43723202 | ||
| The association of diet and thrombotic risk factors in healthy male vegetarians and meat-eaters. | Q43788296 | ||
| Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock! | Q43918759 | ||
| Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis | Q43919085 | ||
| Effect of palm oil carotene on breast cancer tumorigenicity in nude mice | Q44066120 | ||
| Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers | Q44083311 | ||
| Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non-metastasizing malignancy | Q44128613 | ||
| Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer | Q44136002 | ||
| Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus | Q44205749 | ||
| Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume | Q44226068 | ||
| Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial | Q44381365 | ||
| Prostaglandin E2 Suppresses NK Activity In Vivo and Promotes Postoperative Tumor Metastasis in Rats | Q44431969 | ||
| A wholly nutritional 'multifocal angiostatic therapy' for control of disseminated cancer | Q44462149 | ||
| Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells | Q44482258 | ||
| Prostate cancer cell type-specific regulation of the human PTHrP gene via a negative VDRE. | Q44506068 | ||
| Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice | Q44509153 | ||
| Gold compounds inhibit adhesion of human cancer cells to vascular endothelial cells | Q44512775 | ||
| Selenium and immune cell functions. II. Effect on lymphocyte-mediated cytotoxicity | Q44519731 | ||
| Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine | Q44529214 | ||
| Weight loss reduces tissue factor in morbidly obese patients | Q44548928 | ||
| Thrombin induces neoangiogenesis in the chick chorioallantoic membrane | Q44604222 | ||
| Effect of glutamine on the initiation and promotion phases of DMBA‐induced mammary tumor development | Q44657684 | ||
| Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. | Q44675420 | ||
| Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study | Q44685336 | ||
| The association between magnesium intake and fasting insulin concentration in healthy middle-aged women | Q44699048 | ||
| Plasma levels of tissue factor antigen in patients with non-insulin-dependent diabetes mellitus | Q44789225 | ||
| Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). | Q44797217 | ||
| Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation | Q44819483 | ||
| Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes | Q44836090 | ||
| Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). | Q44895898 | ||
| 25-hydroxyvitamin D3-1alpha-hydroxylase expression in normal and malignant human colon. | Q44945503 | ||
| Sub-optimal taurine status may promote platelet hyperaggregability in vegetarians | Q45003165 | ||
| HMG-CoA reductase inhibitors and the risk of vertebral fracture | Q45018992 | ||
| Statin lipid-lowering drugs and bone mineral density | Q45073873 | ||
| Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. | Q45134048 | ||
| A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. | Q45158856 | ||
| Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo | Q45183771 | ||
| Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist | Q45200412 | ||
| Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance | Q45205116 | ||
| Solar radiation, vitamin D and survival rate of colon cancer in Norway | Q45263203 | ||
| Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy | Q45304293 | ||
| Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study | Q45742019 | ||
| Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems | Q46365785 | ||
| Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: effects on circulating IGF-I and its binding proteins in premenopausal women | Q46413160 | ||
| Cyclooxygenase inhibitors modulate NK activities that control metastatic disease | Q46488570 | ||
| Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial | Q46492688 | ||
| The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts | Q46652649 | ||
| 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation | Q46665943 | ||
| Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6). | Q47397491 | ||
| Immuno-potentiating effects of the antler-shaped fruiting body of Ganoderma lucidum (Rokkaku-Reishi). | Q47671495 | ||
| A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro | Q47879899 | ||
| Potentiation of cytotoxic activity in naïve and tumor-bearing mice by oral administration of hot-water extracts from Agaricus brazei fruiting bodies | Q48013976 | ||
| ABC of palliative care. Anorexia, cachexia, and nutrition | Q34065633 | ||
| Thrombosis in cancer patients | Q34083025 | ||
| Vitamin K and bone health | Q34099640 | ||
| Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis | Q34146697 | ||
| Effects of a mushroom mycelium extract on the treatment of prostate cancer | Q34154980 | ||
| The insulin-like growth factor system and cancer | Q34200058 | ||
| Insulin-like growth factor-I in muscle metabolism and myotherapies. | Q34329895 | ||
| Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers. | Q34400266 | ||
| Hypercalcemia of malignancy | Q34437562 | ||
| Intensive lifestyle changes may affect the progression of prostate cancer | Q34442113 | ||
| Platelet-derived growth factor receptors: a therapeutic target in solid tumors | Q34461490 | ||
| Control of protein synthesis by amino acid availability | Q34493700 | ||
| Effect of omega 3 polyunsaturated fatty acid ingestion on bone metabolism and osteoporosis | Q34589619 | ||
| Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection | Q34601336 | ||
| Folic acid and homocysteine in age-related disease | Q34662356 | ||
| The argument for increasing selenium intake | Q34754393 | ||
| Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs | Q34768486 | ||
| Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells | Q34928974 | ||
| Low magnesium and atherosclerosis: an evidence-based link. | Q35049639 | ||
| HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture? | Q35107704 | ||
| Vitamin D in preventive medicine: are we ignoring the evidence? | Q35117137 | ||
| Protective role of n-3 lipids and soy protein in osteoporosis | Q35150595 | ||
| Pathogenesis of increased risk of thrombosis in cancer. | Q35187967 | ||
| Nutritional and clinical relevance of lutein in human health | Q35545380 | ||
| Antiproliferative role of vitamin D and its analogs--a brief overview | Q35584913 | ||
| Selective protein kinase C inhibitors and their applications | Q35610642 | ||
| Natural killer cells and cancer | Q35622883 | ||
| Insulin and cancer | Q35624527 | ||
| Galectin-3 and metastasis | Q35646658 | ||
| The anti-angiogenic basis of metronomic chemotherapy | Q35788112 | ||
| Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer | Q35791879 | ||
| Signaling pathways responsible for cancer cell invasion as targets for cancer therapy | Q35793957 | ||
| Galectin-3 induces endothelial cell morphogenesis and angiogenesis | Q35809815 | ||
| Evidence for a link between IGF-I and cancer. | Q35875689 | ||
| P433 | issue | 2 | |
| P921 | main subject | nutraceutical | Q533025 |
| P304 | page(s) | 150-171 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Integrative Cancer Therapies | Q15708568 |
| P1476 | title | Toward a core nutraceutical program for cancer management | |
| P478 | volume | 5 |
| Q36840442 | Chemopreventive efficacy of silymarin in skin and prostate cancer |
| Q30736359 | Designing a broad-spectrum integrative approach for cancer prevention and treatment. |
| Q40145522 | Effects of silymarin on the spontaneous proliferation and cell cycle of human peripheral blood leukemia T cells |
| Q37127379 | Influence of diet on metastasis and tumor dormancy. |
| Q24651188 | Modified citrus pectin anti-metastatic properties: one bullet, multiple targets |
| Q34171005 | Reduced cancer risk in vegetarians: an analysis of recent reports |
| Q33967052 | Type IIB procollagen NH(2)-propeptide induces death of tumor cells via interaction with integrins alpha(V)beta(3) and alpha(V)beta(5). |
Search more.